Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (18.819)

61

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27

62

PRESTO : A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Aggarwal, R. | Heller, G. | Hillman, D. | +70

CommentIn: Nat Rev Urol. 2024 Mar;21(3):126. - PMID 38355924

63

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype : A Randomized Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Lorusso, D. | Raspagliesi, F. | Ronzulli, D. | +20

64

Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy : A Phase 3 Randomized Clinical Trial in China

enthalten in: Diabetes | 2024

von Guo, L. | Pan, Q. | Cheng, Z. | +10

65

Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor-Related Bone Metastases : A Randomized, Double-Blind, Phase 3 Equivalence Trial

enthalten in: JAMA oncology | 2024

von Zhang, S. | Yin, Y. | Xiong, H. | +36

66

Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer : Final Results of the POUT Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Birtle, A. | Jones, R. | Chester, J. | +14

67

The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients : 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Malagola, M. | Iurlo, A. | Bucelli, C. | +27

68

Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause : effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2)

enthalten in: Menopause (New York, N.Y.) | 2024

von Santoro, N. | Nappi, R. | Neal-Perry, G. | +4

69

Intravesical Interferon Therapy vs Hyaluronic Acid for Pain Among Female Individuals With Interstitial Cystitis : A Randomized Clinical Trial

enthalten in: JAMA network open | 2024

von Shen, S. | Peng, L. | Zeng, X. | +3

70

Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011) : A Phase 3, Randomized, Double-Blind Trial

enthalten in: European urology | 2024

von Matsubara, N. | de Wit, R. | Balar, A. | +18